| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 692021 | Null | 0.00479683626511392 | 0.42511644 |
| NSC 693544 | Null | 0.00479683626511392 | 0.61847352 |
| NSC 715643 | Null | 0.00479683626511392 | 0.40877388 |
| NSC 716524 | Null | 0.00479683626511392 | -0.1804712 |
| NSC 757946 | (1R,2E,6R,10E,11aS,13S,14aR)-1,13-dihydroxy-6-(2-hydroxyethyl)-6,7,8,9,12,13,14,14a-octahydro-1H-cyclopenta[f][1]oxacyclotridecin-4(11aH)-one | 0.00479683626511392 | -0.14753988 |
| NSC 762149 | N-(4-{2-[(1R,6R,11aS,13S,14aR)-1,13-dihydroxy-4-oxo-1,6,7,8,9,11a,12,13,14,14a-decahydro-4H-cyclopenta[f]oxacyclotridecin-6-yl]ethyl}phenyl)acetamide | 0.00479683626511392 | -0.12396506 |
| NSC 107392 | 5-HP | 0.0048681766467277 | 0.28140467 |
| NSC 176328 | Ellipticine, 6-(3-aminopropyl)-, dihydrochloride | 0.0048681766467277 | 0.62050209 |
| NSC 292816 | 1-Butanone, 1,1'-(9-ethyl-9H-carbazole-3,6-diyl)bis[4-(dimethylamino)-, (E)-2-butenedioate (1:1) | 0.0048681766467277 | 0.46934181 |
| NSC 618654 | Null | 0.0048681766467277 | 0.38968763 |